These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29105486)

  • 21. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing.
    Honda M; Kataoka M; Onishi N; Iima M; Ohashi A; Kanao S; Nickel MD; Toi M; Togashi K
    J Magn Reson Imaging; 2020 Jan; 51(1):164-174. PubMed ID: 31215107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of DCE-MR in predicting breast cancer subtypes.
    Macchini M; Ponziani M; Iamurri AP; Pistelli M; De Lisa M; Berardi R; Giuseppetti GM
    Radiol Med; 2018 Oct; 123(10):753-764. PubMed ID: 29869226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?
    van der Velden BHM; Bismeijer T; Canisius S; Loo CE; Lips EH; Wesseling J; Viergever MA; Wessels LFA; Gilhuijs KGA
    Eur J Radiol; 2019 Dec; 121():108705. PubMed ID: 31655316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    Nam SY; Ko ES; Lim Y; Han BK; Ko EY; Choi JS; Lee JE
    PLoS One; 2018; 13(4):e0195756. PubMed ID: 29649266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
    Kang SR; Kim HW; Kim HS
    J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
    Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
    J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
    Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
    Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
    Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
    J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
    Du S; Gao S; Zhang L; Yang X; Qi X; Li S
    Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between dynamic contrast-enhanced magnetic resonance imaging parameters and histopathologic factors in breast cancer.
    Tuan Linh L; Minh Duc N; Tra My TT; Viet Bang L; Minh Thong P
    Clin Ter; 2021 Sep; 172(5):453-460. PubMed ID: 34625779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC).
    Ohashi A; Kataoka M; Kanao S; Iima M; Murata K; Weiland E; Onishi N; Kawai M; Toi M; Togashi K
    Eur J Radiol; 2019 Sep; 118():285-292. PubMed ID: 31324411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis.
    Chaudhury B; Zhou M; Goldgof DB; Hall LO; Gatenby RA; Gillies RJ; Patel BK; Weinfurtner RJ; Drukteinis JS
    J Magn Reson Imaging; 2015 Nov; 42(5):1421-30. PubMed ID: 25884277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer.
    Romeo V; Cavaliere C; Imbriaco M; Verde F; Petretta M; Franzese M; Stanzione A; Cuocolo R; Aiello M; Basso L; Amitrano M; Lauria R; Accurso A; Brunetti A; Salvatore M
    Eur J Radiol; 2020 May; 126():108907. PubMed ID: 32145597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summarizing the 4D image stack of ultrafast dynamic contrast enhancement MRI of breast cancer in 3D using color intensity projections.
    Cover KS; Duvivier KM; de Graaf P; Wittenberg R; Smit R; Kuijer JPA; Hofman MBM; Slotman BJ; Verdaasdonk RM
    J Magn Reson Imaging; 2019 May; 49(5):1391-1399. PubMed ID: 30318731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
    Fasmer KE; Bjørnerud A; Ytre-Hauge S; Grüner R; Tangen IL; Werner HM; Bjørge L; Salvesen ØO; Trovik J; Krakstad C; Haldorsen IS
    Acta Radiol; 2018 Aug; 59(8):1010-1017. PubMed ID: 29137496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.
    Makkat S; Luypaert R; Stadnik T; Bourgain C; Sourbron S; Dujardin M; De Greve J; De Mey J
    Radiology; 2008 Nov; 249(2):471-82. PubMed ID: 18780825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic MRI-derived parameters for hot and cold spots: correlation with breast cancer histopathology.
    He D; Ma D; Jin E
    J BUON; 2012; 17(1):57-64. PubMed ID: 22517694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.